Kiora Pharmaceuticals (NASDAQ:KPRX) Price Target Lowered to $1.00 at Maxim Group

Kiora Pharmaceuticals (NASDAQ:KPRX – Get Rating) had its price objective dropped by research analysts at Maxim Group to $1.00 in a research note issued on Thursday, Stock Target Advisor reports. Maxim Group’s target price points to a potential upside of 149.94% from the company’s previous close. Separately, HC Wainwright dropped their price target on Kiora […]

Related Keywords

United States , ,Geode Capital Management ,Kiora Pharmaceuticals ,Renaissance Technologies ,Blackrock Inc ,Kiora Pharmaceuticals Company Profile Get Rating ,Maxim Group ,Kiora Pharmaceuticals Inc ,Get Rating ,Stock Target Advisor ,Pharmaceuticals Company Profile ,Target Advisor ,Nasdaq Kprx ,Kprx ,Medical ,Lower Price Target ,